DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sudeep Pharma Limited — Updates

NSE 6 hrs ago·6 Aug 2026, 11:17 am

Sudeep Pharma

Sudeep Pharma Limited has informed stock exchanges that it has no material information to disclose at this time.

This brief announcement is a routine update and does not reveal any specific operational or financial details. For investors, it implies that the company is currently not facing any immediate crisis or significant news that requires a formal disclosure under market regulations.

Investors should monitor the company's future filings and official press releases for any material developments. Until further information is available, market activity in the stock is likely to remain driven by general market sentiment rather than specific company news.